AstraZeneca
The Patient Centered Science (PCS) Director leads therapy area and project-level patient‑centered evidence strategies, focusing on clinical outcome assessments, patient‑reported outcomes, and broader patient experience data across the product lifecycle. This role partners with cross‑functional teams to define COA/PRO endpoints, identify evidence gaps, and integrate patient‑centered evidence into clinical plans, regulatory submissions, and market access strategies. The director also manages external vendors, drives scientific communication, and represents PCS with regulatory, HTA, and external stakeholders.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
36% above the average for this role
Patient-Centered Outcomes Research (PCOR) Lead
UCB
(Senior) Principal - Clinical Outcome Assessment Science - Multiple locations
lifelancer
(Senior) Principal - Clinical Outcome Assessment Science - Multiple locations
lifelancer
Senior Clinical Outcomes Assessment (COA/PRO) Manager – HEOR
gloorlang
Patient-Centered Outcomes Research (P-COR) Lead
bayer
(Senior) Principal - Clinical Outcome Assessment Science - Multiple locations
lifelancer